← Leaderboards
John M Nicklas
University Of Michigan At Ann Arbor
$412
Attributed
$412
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$412 · 3
By mechanism
M01$412 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Gail D Winger$8,334,875
- Oliver D Kripfgans$4,825,900
- Mark A Supiano$3,404,723
- Anatoli N Lopatin$4,751,702
- James H Woods$18,938,311
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchCongestive Heart FailureHuman SubjectDrug Screening /EvaluationHeart Disorder ChemotherapyHyponatremiaUrinalysisBlood ChemistryDosageHormone InhibitorHeart VentricleHemodynamicsHemoglobinBody Fluid Balance TherapyExerciseElectrocardiographyCardiovascular Stress TestIntravenous AdministrationLongitudinal Human StudyMorphinansPlacebosQuestionnairesTroponin
Grant awards (4)
Efficacy &safety of IVYM087 in nonhypovolemic hyponatremia$0
M01 · FY2002 · RR
TRK820 IN PATIENTS WITH HYPONATREMIA COINCIDENT WITH CONGESTIVE HEART FAILURE$206
M01 · FY2000 · RR
EXERCISE EFFECTS ON LEFT VENTRICULAR FUNCTION IN CONGESTIVE HEART FAILURE$206
M01 · FY2000 · RR
Efficacy &safety of IVYM087 in nonhypovolemic hyponatremia$0
M01 · FY2000 · RR